2015-2027 Global Bispecific Antibody Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
The worldwide market for Bispecific Antibody is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.
Major Companies Covered
Amgen
Jounce Therapeutics
EMD Serono
Immunomedics
AstraZeneca (MedImmune)
Neovii Biotech
Eli Lilly
Affimed Therapeutics
Roche
Adimab
Ablynx
Sanofi
OncoMed Pharmaceuticals
Pieris
MacroGenics
Emergent BioSolutions
Genmab
Genentech
NovImmune SA
Merus
Regeneron Pharmaceuticals
Chugai Pharmaceutical
Major Types Covered
Catumaxomab (Removab)
Blinatumomab
Duligotumab
SAR 156597
Major Applications Covered
BsMAb for Diagnosis of Infectious Diseases
Diagnosis of Bacterial Infections
Diagnosis of Viral Infections
BsMAb for Cancer Diagnostic
BsAbs Blocking Signaling Pathways
BsAbs Targeting Tumor Angiogenesis
Specific Delivery of Effector Compounds to Targets
Bispecific Antibodies & Gene Therapy
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.
Major Companies Covered
Amgen
Jounce Therapeutics
EMD Serono
Immunomedics
AstraZeneca (MedImmune)
Neovii Biotech
Eli Lilly
Affimed Therapeutics
Roche
Adimab
Ablynx
Sanofi
OncoMed Pharmaceuticals
Pieris
MacroGenics
Emergent BioSolutions
Genmab
Genentech
NovImmune SA
Merus
Regeneron Pharmaceuticals
Chugai Pharmaceutical
Major Types Covered
Catumaxomab (Removab)
Blinatumomab
Duligotumab
SAR 156597
Major Applications Covered
BsMAb for Diagnosis of Infectious Diseases
Diagnosis of Bacterial Infections
Diagnosis of Viral Infections
BsMAb for Cancer Diagnostic
BsAbs Blocking Signaling Pathways
BsAbs Targeting Tumor Angiogenesis
Specific Delivery of Effector Compounds to Targets
Bispecific Antibodies & Gene Therapy
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027
1 INTRODUCTION
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 KEY FINDINGS OF THE STUDY
3 MARKET DYNAMICS
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Bispecific Antibody Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Bispecific Antibody Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 VALUE CHAIN OF THE BISPECIFIC ANTIBODY MARKET
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 GLOBAL BISPECIFIC ANTIBODY MARKET-SEGMENTATION BY TYPE
5.1 Catumaxomab (Removab)
5.2 Blinatumomab
5.3 Duligotumab
5.4 SAR 156597
6 GLOBAL BISPECIFIC ANTIBODY MARKET-SEGMENTATION BY APPLICATION
6.1 BsMAb for Diagnosis of Infectious Diseases
6.2 Diagnosis of Bacterial Infections
6.3 Diagnosis of Viral Infections
6.4 BsMAb for Cancer Diagnostic
6.5 BsAbs Blocking Signaling Pathways
6.6 BsAbs Targeting Tumor Angiogenesis
6.7 Specific Delivery of Effector Compounds to Targets
6.8 Bispecific Antibodies & Gene Therapy
7 GLOBAL BISPECIFIC ANTIBODY MARKET-SEGMENTATION BY MARKETING CHANNEL
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES
8.1 Amgen
8.1.1 Amgen Profile
8.1.2 Amgen Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Amgen Product/Solution Launches and Enhancements Analysis
8.1.4 Amgen Business Overview/Recent Development/Acquisitions
8.2 Jounce Therapeutics
8.2.1 Jounce Therapeutics Profile
8.2.2 Jounce Therapeutics Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Jounce Therapeutics Product/Solution Launches and Enhancements Analysis
8.2.4 Jounce Therapeutics Business Overview/Recent Development/Acquisitions
8.3 EMD Serono
8.3.1 EMD Serono Profile
8.3.2 EMD Serono Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 EMD Serono Product/Solution Launches and Enhancements Analysis
8.3.4 EMD Serono Business Overview/Recent Development/Acquisitions
8.4 Immunomedics
8.4.1 Immunomedics Profile
8.4.2 Immunomedics Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Immunomedics Product/Solution Launches and Enhancements Analysis
8.4.4 Immunomedics Business Overview/Recent Development/Acquisitions
8.5 AstraZeneca (MedImmune)
8.5.1 AstraZeneca (MedImmune) Profile
8.5.2 AstraZeneca (MedImmune) Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 AstraZeneca (MedImmune) Product/Solution Launches and Enhancements Analysis
8.5.4 AstraZeneca (MedImmune) Business Overview/Recent Development/Acquisitions
8.6 Neovii Biotech
8.6.1 Neovii Biotech Profile
8.6.2 Neovii Biotech Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Neovii Biotech Product/Solution Launches and Enhancements Analysis
8.6.4 Neovii Biotech Business Overview/Recent Development/Acquisitions
8.7 Eli Lilly
8.7.1 Eli Lilly Profile
8.7.2 Eli Lilly Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 Eli Lilly Product/Solution Launches and Enhancements Analysis
8.7.4 Eli Lilly Business Overview/Recent Development/Acquisitions
8.8 Affimed Therapeutics
8.8.1 Affimed Therapeutics Profile
8.8.2 Affimed Therapeutics Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Affimed Therapeutics Product/Solution Launches and Enhancements Analysis
8.8.4 Affimed Therapeutics Business Overview/Recent Development/Acquisitions
8.9 Roche
8.9.1 Roche Profile
8.9.2 Roche Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 Roche Product/Solution Launches and Enhancements Analysis
8.9.4 Roche Business Overview/Recent Development/Acquisitions
8.10 Adimab
8.10.1 Adimab Profile
8.10.2 Adimab Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 Adimab Product/Solution Launches and Enhancements Analysis
8.10.4 Adimab Business Overview/Recent Development/Acquisitions
8.11 Ablynx
8.11.1 Ablynx Profile
8.11.2 Ablynx Sales, Growth Rate and Global Market Share from 2015-2020
8.11.3 Ablynx Product/Solution Launches and Enhancements Analysis
8.11.4 Ablynx Business Overview/Recent Development/Acquisitions
8.12 Sanofi
8.12.1 Sanofi Profile
8.12.2 Sanofi Sales, Growth Rate and Global Market Share from 2015-2020
8.12.3 Sanofi Product/Solution Launches and Enhancements Analysis
8.12.4 Sanofi Business Overview/Recent Development/Acquisitions
8.13 OncoMed Pharmaceuticals
8.13.1 OncoMed Pharmaceuticals Profile
8.13.2 OncoMed Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.13.3 OncoMed Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.13.4 OncoMed Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.14 Pieris
8.14.1 Pieris Profile
8.14.2 Pieris Sales, Growth Rate and Global Market Share from 2015-2020
8.14.3 Pieris Product/Solution Launches and Enhancements Analysis
8.14.4 Pieris Business Overview/Recent Development/Acquisitions
8.15 MacroGenics
8.15.1 MacroGenics Profile
8.15.2 MacroGenics Sales, Growth Rate and Global Market Share from 2015-2020
8.15.3 MacroGenics Product/Solution Launches and Enhancements Analysis
8.15.4 MacroGenics Business Overview/Recent Development/Acquisitions
8.16 Emergent BioSolutions
8.16.1 Emergent BioSolutions Profile
8.16.2 Emergent BioSolutions Sales, Growth Rate and Global Market Share from 2015-2020
8.16.3 Emergent BioSolutions Product/Solution Launches and Enhancements Analysis
8.16.4 Emergent BioSolutions Business Overview/Recent Development/Acquisitions
8.17 Genmab
8.17.1 Genmab Profile
8.17.2 Genmab Sales, Growth Rate and Global Market Share from 2015-2020
8.17.3 Genmab Product/Solution Launches and Enhancements Analysis
8.17.4 Genmab Business Overview/Recent Development/Acquisitions
8.18 Genentech
8.18.1 Genentech Profile
8.18.2 Genentech Sales, Growth Rate and Global Market Share from 2015-2020
8.18.3 Genentech Product/Solution Launches and Enhancements Analysis
8.18.4 Genentech Business Overview/Recent Development/Acquisitions
8.19 NovImmune SA
8.19.1 NovImmune SA Profile
8.19.2 NovImmune SA Sales, Growth Rate and Global Market Share from 2015-2020
8.19.3 NovImmune SA Product/Solution Launches and Enhancements Analysis
8.19.4 NovImmune SA Business Overview/Recent Development/Acquisitions
8.20 Merus
8.20.1 Merus Profile
8.20.2 Merus Sales, Growth Rate and Global Market Share from 2015-2020
8.20.3 Merus Product/Solution Launches and Enhancements Analysis
8.20.4 Merus Business Overview/Recent Development/Acquisitions
8.21 Regeneron Pharmaceuticals
8.21.1 Regeneron Pharmaceuticals Profile
8.21.2 Regeneron Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.21.3 Regeneron Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.21.4 Regeneron Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.22 Chugai Pharmaceutical
8.22.1 Chugai Pharmaceutical Profile
8.22.2 Chugai Pharmaceutical Sales, Growth Rate and Global Market Share from 2015-2020
8.22.3 Chugai Pharmaceutical Product/Solution Launches and Enhancements Analysis
8.22.4 Chugai Pharmaceutical Business Overview/Recent Development/Acquisitions
9 GLOBAL BISPECIFIC ANTIBODY MARKET-SEGMENTATION BY GEOGRAPHY
10 NORTH AMERICA
10.1 North America Bispecific Antibody Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Bispecific Antibody Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Bispecific Antibody Production Analysis from 2015-2020
10.4 North America Bispecific Antibody Consumption Analysis from 2015-2020
10.5 North America Bispecific Antibody Import and Export from 2015-2020
10.6 North America Bispecific Antibody Value, Production and Market Share by Type (2015-2020)
10.7 North America Bispecific Antibody Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Bispecific Antibody by Country (United States, Canada)
10.8.1 North America Bispecific Antibody Sales by Country (2015-2020)
10.8.2 North America Bispecific Antibody Consumption Value by Country (2015-2020)
10.9 North America Bispecific Antibody Market PEST Analysis
11 EUROPE
11.1 Europe Bispecific Antibody Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Bispecific Antibody Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Bispecific Antibody Production Analysis from 2015-2020
11.4 Europe Bispecific Antibody Consumption Analysis from 2015-2020
11.5 Europe Bispecific Antibody Import and Export from 2015-2020
11.6 Europe Bispecific Antibody Value, Production and Market Share by Type (2015-2020)
11.7 Europe Bispecific Antibody Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Bispecific Antibody by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Bispecific Antibody Sales by Country (2015-2020)
11.8.2 Europe Bispecific Antibody Consumption Value by Country (2015-2020)
11.9 Europe Bispecific Antibody Market PEST Analysis
12 ASIA-PACIFIC
12.1 Asia-Pacific Bispecific Antibody Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Bispecific Antibody Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Bispecific Antibody Production Analysis from 2015-2020
12.4 Asia-Pacific Bispecific Antibody Consumption Analysis from 2015-2020
12.5 Asia-Pacific Bispecific Antibody Import and Export from 2015-2020
12.6 Asia-Pacific Bispecific Antibody Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Bispecific Antibody Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Bispecific Antibody by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Bispecific Antibody Sales by Country (2015-2020)
12.8.2 Asia-Pacific Bispecific Antibody Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Bispecific Antibody Market PEST Analysis
13 LATIN AMERICA
13.1 Latin America Bispecific Antibody Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Bispecific Antibody Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Bispecific Antibody Production Analysis from 2015-2020
13.4 Latin America Bispecific Antibody Consumption Analysis from 2015-2020
13.5 Latin America Bispecific Antibody Import and Export from 2015-2020
13.6 Latin America Bispecific Antibody Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Bispecific Antibody Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Bispecific Antibody by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Bispecific Antibody Sales by Country (2015-2020)
13.8.2 Latin America Bispecific Antibody Consumption Value by Country (2015-2020)
13.9 Latin America Bispecific Antibody Market PEST Analysis
14 MIDDLE EAST & AFRICA
14.1 Middle East & Africa Bispecific Antibody Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Bispecific Antibody Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Bispecific Antibody Production Analysis from 2015-2020
14.4 Middle East & Africa Bispecific Antibody Consumption Analysis from 2015-2020
14.5 Middle East & Africa Bispecific Antibody Import and Export from 2015-2020
14.6 Middle East & Africa Bispecific Antibody Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Bispecific Antibody Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Bispecific Antibody by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Bispecific Antibody Sales by Country (2015-2020)
14.8.2 Middle East & Africa Bispecific Antibody Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Bispecific Antibody Market PEST Analysis
15 FUTURE FORECAST OF THE GLOBAL BISPECIFIC ANTIBODY MARKET FROM 2020-2027
15.1 Future Forecast of the Global Bispecific Antibody Market from 2020-2027 Segment by Region
15.2 Global Bispecific Antibody Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Bispecific Antibody Consumption and Growth Rate Forecast by Application (2020-2027)
16 APPENDIX
16.1 Methodology
16.2 Research Data Source
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 KEY FINDINGS OF THE STUDY
3 MARKET DYNAMICS
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Bispecific Antibody Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Bispecific Antibody Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 VALUE CHAIN OF THE BISPECIFIC ANTIBODY MARKET
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 GLOBAL BISPECIFIC ANTIBODY MARKET-SEGMENTATION BY TYPE
5.1 Catumaxomab (Removab)
5.2 Blinatumomab
5.3 Duligotumab
5.4 SAR 156597
6 GLOBAL BISPECIFIC ANTIBODY MARKET-SEGMENTATION BY APPLICATION
6.1 BsMAb for Diagnosis of Infectious Diseases
6.2 Diagnosis of Bacterial Infections
6.3 Diagnosis of Viral Infections
6.4 BsMAb for Cancer Diagnostic
6.5 BsAbs Blocking Signaling Pathways
6.6 BsAbs Targeting Tumor Angiogenesis
6.7 Specific Delivery of Effector Compounds to Targets
6.8 Bispecific Antibodies & Gene Therapy
7 GLOBAL BISPECIFIC ANTIBODY MARKET-SEGMENTATION BY MARKETING CHANNEL
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES
8.1 Amgen
8.1.1 Amgen Profile
8.1.2 Amgen Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Amgen Product/Solution Launches and Enhancements Analysis
8.1.4 Amgen Business Overview/Recent Development/Acquisitions
8.2 Jounce Therapeutics
8.2.1 Jounce Therapeutics Profile
8.2.2 Jounce Therapeutics Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Jounce Therapeutics Product/Solution Launches and Enhancements Analysis
8.2.4 Jounce Therapeutics Business Overview/Recent Development/Acquisitions
8.3 EMD Serono
8.3.1 EMD Serono Profile
8.3.2 EMD Serono Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 EMD Serono Product/Solution Launches and Enhancements Analysis
8.3.4 EMD Serono Business Overview/Recent Development/Acquisitions
8.4 Immunomedics
8.4.1 Immunomedics Profile
8.4.2 Immunomedics Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Immunomedics Product/Solution Launches and Enhancements Analysis
8.4.4 Immunomedics Business Overview/Recent Development/Acquisitions
8.5 AstraZeneca (MedImmune)
8.5.1 AstraZeneca (MedImmune) Profile
8.5.2 AstraZeneca (MedImmune) Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 AstraZeneca (MedImmune) Product/Solution Launches and Enhancements Analysis
8.5.4 AstraZeneca (MedImmune) Business Overview/Recent Development/Acquisitions
8.6 Neovii Biotech
8.6.1 Neovii Biotech Profile
8.6.2 Neovii Biotech Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Neovii Biotech Product/Solution Launches and Enhancements Analysis
8.6.4 Neovii Biotech Business Overview/Recent Development/Acquisitions
8.7 Eli Lilly
8.7.1 Eli Lilly Profile
8.7.2 Eli Lilly Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 Eli Lilly Product/Solution Launches and Enhancements Analysis
8.7.4 Eli Lilly Business Overview/Recent Development/Acquisitions
8.8 Affimed Therapeutics
8.8.1 Affimed Therapeutics Profile
8.8.2 Affimed Therapeutics Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Affimed Therapeutics Product/Solution Launches and Enhancements Analysis
8.8.4 Affimed Therapeutics Business Overview/Recent Development/Acquisitions
8.9 Roche
8.9.1 Roche Profile
8.9.2 Roche Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 Roche Product/Solution Launches and Enhancements Analysis
8.9.4 Roche Business Overview/Recent Development/Acquisitions
8.10 Adimab
8.10.1 Adimab Profile
8.10.2 Adimab Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 Adimab Product/Solution Launches and Enhancements Analysis
8.10.4 Adimab Business Overview/Recent Development/Acquisitions
8.11 Ablynx
8.11.1 Ablynx Profile
8.11.2 Ablynx Sales, Growth Rate and Global Market Share from 2015-2020
8.11.3 Ablynx Product/Solution Launches and Enhancements Analysis
8.11.4 Ablynx Business Overview/Recent Development/Acquisitions
8.12 Sanofi
8.12.1 Sanofi Profile
8.12.2 Sanofi Sales, Growth Rate and Global Market Share from 2015-2020
8.12.3 Sanofi Product/Solution Launches and Enhancements Analysis
8.12.4 Sanofi Business Overview/Recent Development/Acquisitions
8.13 OncoMed Pharmaceuticals
8.13.1 OncoMed Pharmaceuticals Profile
8.13.2 OncoMed Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.13.3 OncoMed Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.13.4 OncoMed Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.14 Pieris
8.14.1 Pieris Profile
8.14.2 Pieris Sales, Growth Rate and Global Market Share from 2015-2020
8.14.3 Pieris Product/Solution Launches and Enhancements Analysis
8.14.4 Pieris Business Overview/Recent Development/Acquisitions
8.15 MacroGenics
8.15.1 MacroGenics Profile
8.15.2 MacroGenics Sales, Growth Rate and Global Market Share from 2015-2020
8.15.3 MacroGenics Product/Solution Launches and Enhancements Analysis
8.15.4 MacroGenics Business Overview/Recent Development/Acquisitions
8.16 Emergent BioSolutions
8.16.1 Emergent BioSolutions Profile
8.16.2 Emergent BioSolutions Sales, Growth Rate and Global Market Share from 2015-2020
8.16.3 Emergent BioSolutions Product/Solution Launches and Enhancements Analysis
8.16.4 Emergent BioSolutions Business Overview/Recent Development/Acquisitions
8.17 Genmab
8.17.1 Genmab Profile
8.17.2 Genmab Sales, Growth Rate and Global Market Share from 2015-2020
8.17.3 Genmab Product/Solution Launches and Enhancements Analysis
8.17.4 Genmab Business Overview/Recent Development/Acquisitions
8.18 Genentech
8.18.1 Genentech Profile
8.18.2 Genentech Sales, Growth Rate and Global Market Share from 2015-2020
8.18.3 Genentech Product/Solution Launches and Enhancements Analysis
8.18.4 Genentech Business Overview/Recent Development/Acquisitions
8.19 NovImmune SA
8.19.1 NovImmune SA Profile
8.19.2 NovImmune SA Sales, Growth Rate and Global Market Share from 2015-2020
8.19.3 NovImmune SA Product/Solution Launches and Enhancements Analysis
8.19.4 NovImmune SA Business Overview/Recent Development/Acquisitions
8.20 Merus
8.20.1 Merus Profile
8.20.2 Merus Sales, Growth Rate and Global Market Share from 2015-2020
8.20.3 Merus Product/Solution Launches and Enhancements Analysis
8.20.4 Merus Business Overview/Recent Development/Acquisitions
8.21 Regeneron Pharmaceuticals
8.21.1 Regeneron Pharmaceuticals Profile
8.21.2 Regeneron Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.21.3 Regeneron Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.21.4 Regeneron Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.22 Chugai Pharmaceutical
8.22.1 Chugai Pharmaceutical Profile
8.22.2 Chugai Pharmaceutical Sales, Growth Rate and Global Market Share from 2015-2020
8.22.3 Chugai Pharmaceutical Product/Solution Launches and Enhancements Analysis
8.22.4 Chugai Pharmaceutical Business Overview/Recent Development/Acquisitions
9 GLOBAL BISPECIFIC ANTIBODY MARKET-SEGMENTATION BY GEOGRAPHY
10 NORTH AMERICA
10.1 North America Bispecific Antibody Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Bispecific Antibody Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Bispecific Antibody Production Analysis from 2015-2020
10.4 North America Bispecific Antibody Consumption Analysis from 2015-2020
10.5 North America Bispecific Antibody Import and Export from 2015-2020
10.6 North America Bispecific Antibody Value, Production and Market Share by Type (2015-2020)
10.7 North America Bispecific Antibody Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Bispecific Antibody by Country (United States, Canada)
10.8.1 North America Bispecific Antibody Sales by Country (2015-2020)
10.8.2 North America Bispecific Antibody Consumption Value by Country (2015-2020)
10.9 North America Bispecific Antibody Market PEST Analysis
11 EUROPE
11.1 Europe Bispecific Antibody Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Bispecific Antibody Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Bispecific Antibody Production Analysis from 2015-2020
11.4 Europe Bispecific Antibody Consumption Analysis from 2015-2020
11.5 Europe Bispecific Antibody Import and Export from 2015-2020
11.6 Europe Bispecific Antibody Value, Production and Market Share by Type (2015-2020)
11.7 Europe Bispecific Antibody Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Bispecific Antibody by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Bispecific Antibody Sales by Country (2015-2020)
11.8.2 Europe Bispecific Antibody Consumption Value by Country (2015-2020)
11.9 Europe Bispecific Antibody Market PEST Analysis
12 ASIA-PACIFIC
12.1 Asia-Pacific Bispecific Antibody Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Bispecific Antibody Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Bispecific Antibody Production Analysis from 2015-2020
12.4 Asia-Pacific Bispecific Antibody Consumption Analysis from 2015-2020
12.5 Asia-Pacific Bispecific Antibody Import and Export from 2015-2020
12.6 Asia-Pacific Bispecific Antibody Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Bispecific Antibody Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Bispecific Antibody by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Bispecific Antibody Sales by Country (2015-2020)
12.8.2 Asia-Pacific Bispecific Antibody Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Bispecific Antibody Market PEST Analysis
13 LATIN AMERICA
13.1 Latin America Bispecific Antibody Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Bispecific Antibody Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Bispecific Antibody Production Analysis from 2015-2020
13.4 Latin America Bispecific Antibody Consumption Analysis from 2015-2020
13.5 Latin America Bispecific Antibody Import and Export from 2015-2020
13.6 Latin America Bispecific Antibody Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Bispecific Antibody Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Bispecific Antibody by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Bispecific Antibody Sales by Country (2015-2020)
13.8.2 Latin America Bispecific Antibody Consumption Value by Country (2015-2020)
13.9 Latin America Bispecific Antibody Market PEST Analysis
14 MIDDLE EAST & AFRICA
14.1 Middle East & Africa Bispecific Antibody Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Bispecific Antibody Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Bispecific Antibody Production Analysis from 2015-2020
14.4 Middle East & Africa Bispecific Antibody Consumption Analysis from 2015-2020
14.5 Middle East & Africa Bispecific Antibody Import and Export from 2015-2020
14.6 Middle East & Africa Bispecific Antibody Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Bispecific Antibody Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Bispecific Antibody by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Bispecific Antibody Sales by Country (2015-2020)
14.8.2 Middle East & Africa Bispecific Antibody Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Bispecific Antibody Market PEST Analysis
15 FUTURE FORECAST OF THE GLOBAL BISPECIFIC ANTIBODY MARKET FROM 2020-2027
15.1 Future Forecast of the Global Bispecific Antibody Market from 2020-2027 Segment by Region
15.2 Global Bispecific Antibody Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Bispecific Antibody Consumption and Growth Rate Forecast by Application (2020-2027)
16 APPENDIX
16.1 Methodology
16.2 Research Data Source
LIST OF TABLES AND FIGURES
Global Bispecific Antibody Market Value ($) and Growth Rate of Bispecific Antibody from 2015-2027
Global Bispecific Antibody Production and Growth Rate Segment by Product Type from 2015-2027
Global Bispecific Antibody Consumption and Growth Rate Segment by Application from 2015-2027
Figure Bispecific Antibody Picture
Table Product Specifications of Bispecific Antibody
Table Driving Factors for this Market
Table Industry News of Bispecific Antibody Market
Figure Value Chain Status of Bispecific Antibody
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Bispecific Antibody Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Bispecific Antibody Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Catumaxomab (Removab) of Bispecific Antibody
Figure Blinatumomab of Bispecific Antibody
Figure Duligotumab of Bispecific Antibody
Figure SAR 156597 of Bispecific Antibody
Table Global Bispecific Antibody Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Bispecific Antibody Value ($) and Growth Rate Segment by Application from 2015-2020
Figure BsMAb for Diagnosis of Infectious Diseases of Bispecific Antibody
Figure Diagnosis of Bacterial Infections of Bispecific Antibody
Figure Diagnosis of Viral Infections of Bispecific Antibody
Figure BsMAb for Cancer Diagnostic of Bispecific Antibody
Figure BsAbs Blocking Signaling Pathways of Bispecific Antibody
Figure BsAbs Targeting Tumor Angiogenesis of Bispecific Antibody
Figure Specific Delivery of Effector Compounds to Targets of Bispecific Antibody
Figure Bispecific Antibodies & Gene Therapy of Bispecific Antibody
Table Global Bispecific Antibody Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Bispecific Antibody Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Bispecific Antibody
Figure Online Channel of Bispecific Antibody
Table Amgen Profile (Company Name, Plants Distribution, Sales Region)
Figure Amgen Sales and Growth Rate from 2015-2020
Figure Amgen Revenue ($) and Global Market Share from 2015-2020
Table Amgen Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Jounce Therapeutics Profile (Company Name, Plants Distribution, Sales Region)
Figure Jounce Therapeutics Sales and Growth Rate from 2015-2020
Figure Jounce Therapeutics Revenue ($) and Global Market Share from 2015-2020
Table Jounce Therapeutics Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table EMD Serono Profile (Company Name, Plants Distribution, Sales Region)
Figure EMD Serono Sales and Growth Rate from 2015-2020
Figure EMD Serono Revenue ($) and Global Market Share from 2015-2020
Table EMD Serono Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Immunomedics Profile (Company Name, Plants Distribution, Sales Region)
Figure Immunomedics Sales and Growth Rate from 2015-2020
Figure Immunomedics Revenue ($) and Global Market Share from 2015-2020
Table Immunomedics Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table AstraZeneca (MedImmune) Profile (Company Name, Plants Distribution, Sales Region)
Figure AstraZeneca (MedImmune) Sales and Growth Rate from 2015-2020
Figure AstraZeneca (MedImmune) Revenue ($) and Global Market Share from 2015-2020
Table AstraZeneca (MedImmune) Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Neovii Biotech Profile (Company Name, Plants Distribution, Sales Region)
Figure Neovii Biotech Sales and Growth Rate from 2015-2020
Figure Neovii Biotech Revenue ($) and Global Market Share from 2015-2020
Table Neovii Biotech Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Eli Lilly Profile (Company Name, Plants Distribution, Sales Region)
Figure Eli Lilly Sales and Growth Rate from 2015-2020
Figure Eli Lilly Revenue ($) and Global Market Share from 2015-2020
Table Eli Lilly Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Affimed Therapeutics Profile (Company Name, Plants Distribution, Sales Region)
Figure Affimed Therapeutics Sales and Growth Rate from 2015-2020
Figure Affimed Therapeutics Revenue ($) and Global Market Share from 2015-2020
Table Affimed Therapeutics Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Roche Profile (Company Name, Plants Distribution, Sales Region)
Figure Roche Sales and Growth Rate from 2015-2020
Figure Roche Revenue ($) and Global Market Share from 2015-2020
Table Roche Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Adimab Profile (Company Name, Plants Distribution, Sales Region)
Figure Adimab Sales and Growth Rate from 2015-2020
Figure Adimab Revenue ($) and Global Market Share from 2015-2020
Table Adimab Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Ablynx Profile (Company Name, Plants Distribution, Sales Region)
Figure Ablynx Sales and Growth Rate from 2015-2020
Figure Ablynx Revenue ($) and Global Market Share from 2015-2020
Table Ablynx Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sanofi Profile (Company Name, Plants Distribution, Sales Region)
Figure Sanofi Sales and Growth Rate from 2015-2020
Figure Sanofi Revenue ($) and Global Market Share from 2015-2020
Table Sanofi Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table OncoMed Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure OncoMed Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure OncoMed Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table OncoMed Pharmaceuticals Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pieris Profile (Company Name, Plants Distribution, Sales Region)
Figure Pieris Sales and Growth Rate from 2015-2020
Figure Pieris Revenue ($) and Global Market Share from 2015-2020
Table Pieris Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table MacroGenics Profile (Company Name, Plants Distribution, Sales Region)
Figure MacroGenics Sales and Growth Rate from 2015-2020
Figure MacroGenics Revenue ($) and Global Market Share from 2015-2020
Table MacroGenics Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Emergent BioSolutions Profile (Company Name, Plants Distribution, Sales Region)
Figure Emergent BioSolutions Sales and Growth Rate from 2015-2020
Figure Emergent BioSolutions Revenue ($) and Global Market Share from 2015-2020
Table Emergent BioSolutions Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Genmab Profile (Company Name, Plants Distribution, Sales Region)
Figure Genmab Sales and Growth Rate from 2015-2020
Figure Genmab Revenue ($) and Global Market Share from 2015-2020
Table Genmab Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Genentech Profile (Company Name, Plants Distribution, Sales Region)
Figure Genentech Sales and Growth Rate from 2015-2020
Figure Genentech Revenue ($) and Global Market Share from 2015-2020
Table Genentech Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table NovImmune SA Profile (Company Name, Plants Distribution, Sales Region)
Figure NovImmune SA Sales and Growth Rate from 2015-2020
Figure NovImmune SA Revenue ($) and Global Market Share from 2015-2020
Table NovImmune SA Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Merus Profile (Company Name, Plants Distribution, Sales Region)
Figure Merus Sales and Growth Rate from 2015-2020
Figure Merus Revenue ($) and Global Market Share from 2015-2020
Table Merus Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Regeneron Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Regeneron Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Regeneron Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Regeneron Pharmaceuticals Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Chugai Pharmaceutical Profile (Company Name, Plants Distribution, Sales Region)
Figure Chugai Pharmaceutical Sales and Growth Rate from 2015-2020
Figure Chugai Pharmaceutical Revenue ($) and Global Market Share from 2015-2020
Table Chugai Pharmaceutical Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Bispecific Antibody Production Value ($) by Region from 2015-2020
Table Global Bispecific Antibody Production Value Share by Region from 2015-2020
Table Global Bispecific Antibody Production by Region from 2015-2020
Table Global Bispecific Antibody Consumption Value ($) by Region from 2015-2020
Table Global Bispecific Antibody Consumption by Region from 2015-2020
Table North America Bispecific Antibody Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Bispecific Antibody Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Bispecific Antibody Import and Export from 2015-2020
Table North America Bispecific Antibody Value ($) by Type (2015-2020)
Table North America Bispecific Antibody Production by Type (2015-2020)
Table North America Bispecific Antibody Consumption by Application (2015-2020)
Table North America Bispecific Antibody Consumption by Country (2015-2020)
Table North America Bispecific Antibody Consumption Value ($) by Country (2015-2020)
Figure North America Bispecific Antibody Market PEST Analysis
Table Europe Bispecific Antibody Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Bispecific Antibody Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Bispecific Antibody Import and Export from 2015-2020
Table Europe Bispecific Antibody Value ($) by Type (2015-2020)
Table Europe Bispecific Antibody Production by Type (2015-2020)
Table Europe Bispecific Antibody Consumption by Application (2015-2020)
Table Europe Bispecific Antibody Consumption by Country (2015-2020)
Table Europe Bispecific Antibody Consumption Value ($) by Country (2015-2020)
Figure Europe Bispecific Antibody Market PEST Analysis
Table Asia-Pacific Bispecific Antibody Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Bispecific Antibody Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Bispecific Antibody Import and Export from 2015-2020
Table Asia-Pacific Bispecific Antibody Value ($) by Type (2015-2020)
Table Asia-Pacific Bispecific Antibody Production by Type (2015-2020)
Table Asia-Pacific Bispecific Antibody Consumption by Application (2015-2020)
Table Asia-Pacific Bispecific Antibody Consumption by Country (2015-2020)
Table Asia-Pacific Bispecific Antibody Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Bispecific Antibody Market PEST Analysis
Table Latin America Bispecific Antibody Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Bispecific Antibody Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Bispecific Antibody Import and Export from 2015-2020
Table Latin America Bispecific Antibody Value ($) by Type (2015-2020)
Table Latin America Bispecific Antibody Production by Type (2015-2020)
Table Latin America Bispecific Antibody Consumption by Application (2015-2020)
Table Latin America Bispecific Antibody Consumption by Country (2015-2020)
Table Latin America Bispecific Antibody Consumption Value ($) by Country (2015-2020)
Figure Latin America Bispecific Antibody Market PEST Analysis
Table Middle East & Africa Bispecific Antibody Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Bispecific Antibody Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Bispecific Antibody Import and Export from 2015-2020
Table Middle East & Africa Bispecific Antibody Value ($) by Type (2015-2020)
Table Middle East & Africa Bispecific Antibody Production by Type (2015-2020)
Table Middle East & Africa Bispecific Antibody Consumption by Application (2015-2020)
Table Middle East & Africa Bispecific Antibody Consumption by Country (2015-2020)
Table Middle East & Africa Bispecific Antibody Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Bispecific Antibody Market PEST Analysis
Table Global Bispecific Antibody Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Bispecific Antibody Production and Growth Rate Forecast by Region (2020-2027)
Table Global Bispecific Antibody Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Bispecific Antibody Production and Growth Rate Forecast by Type (2020-2027)
Table Global Bispecific Antibody Consumption and Growth Rate Forecast by Application (2020-2027)
Global Bispecific Antibody Market Value ($) and Growth Rate of Bispecific Antibody from 2015-2027
Global Bispecific Antibody Production and Growth Rate Segment by Product Type from 2015-2027
Global Bispecific Antibody Consumption and Growth Rate Segment by Application from 2015-2027
Figure Bispecific Antibody Picture
Table Product Specifications of Bispecific Antibody
Table Driving Factors for this Market
Table Industry News of Bispecific Antibody Market
Figure Value Chain Status of Bispecific Antibody
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Bispecific Antibody Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Bispecific Antibody Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Catumaxomab (Removab) of Bispecific Antibody
Figure Blinatumomab of Bispecific Antibody
Figure Duligotumab of Bispecific Antibody
Figure SAR 156597 of Bispecific Antibody
Table Global Bispecific Antibody Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Bispecific Antibody Value ($) and Growth Rate Segment by Application from 2015-2020
Figure BsMAb for Diagnosis of Infectious Diseases of Bispecific Antibody
Figure Diagnosis of Bacterial Infections of Bispecific Antibody
Figure Diagnosis of Viral Infections of Bispecific Antibody
Figure BsMAb for Cancer Diagnostic of Bispecific Antibody
Figure BsAbs Blocking Signaling Pathways of Bispecific Antibody
Figure BsAbs Targeting Tumor Angiogenesis of Bispecific Antibody
Figure Specific Delivery of Effector Compounds to Targets of Bispecific Antibody
Figure Bispecific Antibodies & Gene Therapy of Bispecific Antibody
Table Global Bispecific Antibody Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Bispecific Antibody Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Bispecific Antibody
Figure Online Channel of Bispecific Antibody
Table Amgen Profile (Company Name, Plants Distribution, Sales Region)
Figure Amgen Sales and Growth Rate from 2015-2020
Figure Amgen Revenue ($) and Global Market Share from 2015-2020
Table Amgen Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Jounce Therapeutics Profile (Company Name, Plants Distribution, Sales Region)
Figure Jounce Therapeutics Sales and Growth Rate from 2015-2020
Figure Jounce Therapeutics Revenue ($) and Global Market Share from 2015-2020
Table Jounce Therapeutics Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table EMD Serono Profile (Company Name, Plants Distribution, Sales Region)
Figure EMD Serono Sales and Growth Rate from 2015-2020
Figure EMD Serono Revenue ($) and Global Market Share from 2015-2020
Table EMD Serono Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Immunomedics Profile (Company Name, Plants Distribution, Sales Region)
Figure Immunomedics Sales and Growth Rate from 2015-2020
Figure Immunomedics Revenue ($) and Global Market Share from 2015-2020
Table Immunomedics Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table AstraZeneca (MedImmune) Profile (Company Name, Plants Distribution, Sales Region)
Figure AstraZeneca (MedImmune) Sales and Growth Rate from 2015-2020
Figure AstraZeneca (MedImmune) Revenue ($) and Global Market Share from 2015-2020
Table AstraZeneca (MedImmune) Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Neovii Biotech Profile (Company Name, Plants Distribution, Sales Region)
Figure Neovii Biotech Sales and Growth Rate from 2015-2020
Figure Neovii Biotech Revenue ($) and Global Market Share from 2015-2020
Table Neovii Biotech Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Eli Lilly Profile (Company Name, Plants Distribution, Sales Region)
Figure Eli Lilly Sales and Growth Rate from 2015-2020
Figure Eli Lilly Revenue ($) and Global Market Share from 2015-2020
Table Eli Lilly Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Affimed Therapeutics Profile (Company Name, Plants Distribution, Sales Region)
Figure Affimed Therapeutics Sales and Growth Rate from 2015-2020
Figure Affimed Therapeutics Revenue ($) and Global Market Share from 2015-2020
Table Affimed Therapeutics Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Roche Profile (Company Name, Plants Distribution, Sales Region)
Figure Roche Sales and Growth Rate from 2015-2020
Figure Roche Revenue ($) and Global Market Share from 2015-2020
Table Roche Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Adimab Profile (Company Name, Plants Distribution, Sales Region)
Figure Adimab Sales and Growth Rate from 2015-2020
Figure Adimab Revenue ($) and Global Market Share from 2015-2020
Table Adimab Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Ablynx Profile (Company Name, Plants Distribution, Sales Region)
Figure Ablynx Sales and Growth Rate from 2015-2020
Figure Ablynx Revenue ($) and Global Market Share from 2015-2020
Table Ablynx Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sanofi Profile (Company Name, Plants Distribution, Sales Region)
Figure Sanofi Sales and Growth Rate from 2015-2020
Figure Sanofi Revenue ($) and Global Market Share from 2015-2020
Table Sanofi Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table OncoMed Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure OncoMed Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure OncoMed Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table OncoMed Pharmaceuticals Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pieris Profile (Company Name, Plants Distribution, Sales Region)
Figure Pieris Sales and Growth Rate from 2015-2020
Figure Pieris Revenue ($) and Global Market Share from 2015-2020
Table Pieris Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table MacroGenics Profile (Company Name, Plants Distribution, Sales Region)
Figure MacroGenics Sales and Growth Rate from 2015-2020
Figure MacroGenics Revenue ($) and Global Market Share from 2015-2020
Table MacroGenics Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Emergent BioSolutions Profile (Company Name, Plants Distribution, Sales Region)
Figure Emergent BioSolutions Sales and Growth Rate from 2015-2020
Figure Emergent BioSolutions Revenue ($) and Global Market Share from 2015-2020
Table Emergent BioSolutions Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Genmab Profile (Company Name, Plants Distribution, Sales Region)
Figure Genmab Sales and Growth Rate from 2015-2020
Figure Genmab Revenue ($) and Global Market Share from 2015-2020
Table Genmab Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Genentech Profile (Company Name, Plants Distribution, Sales Region)
Figure Genentech Sales and Growth Rate from 2015-2020
Figure Genentech Revenue ($) and Global Market Share from 2015-2020
Table Genentech Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table NovImmune SA Profile (Company Name, Plants Distribution, Sales Region)
Figure NovImmune SA Sales and Growth Rate from 2015-2020
Figure NovImmune SA Revenue ($) and Global Market Share from 2015-2020
Table NovImmune SA Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Merus Profile (Company Name, Plants Distribution, Sales Region)
Figure Merus Sales and Growth Rate from 2015-2020
Figure Merus Revenue ($) and Global Market Share from 2015-2020
Table Merus Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Regeneron Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Regeneron Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Regeneron Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Regeneron Pharmaceuticals Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Chugai Pharmaceutical Profile (Company Name, Plants Distribution, Sales Region)
Figure Chugai Pharmaceutical Sales and Growth Rate from 2015-2020
Figure Chugai Pharmaceutical Revenue ($) and Global Market Share from 2015-2020
Table Chugai Pharmaceutical Bispecific Antibody Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Bispecific Antibody Production Value ($) by Region from 2015-2020
Table Global Bispecific Antibody Production Value Share by Region from 2015-2020
Table Global Bispecific Antibody Production by Region from 2015-2020
Table Global Bispecific Antibody Consumption Value ($) by Region from 2015-2020
Table Global Bispecific Antibody Consumption by Region from 2015-2020
Table North America Bispecific Antibody Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Bispecific Antibody Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Bispecific Antibody Import and Export from 2015-2020
Table North America Bispecific Antibody Value ($) by Type (2015-2020)
Table North America Bispecific Antibody Production by Type (2015-2020)
Table North America Bispecific Antibody Consumption by Application (2015-2020)
Table North America Bispecific Antibody Consumption by Country (2015-2020)
Table North America Bispecific Antibody Consumption Value ($) by Country (2015-2020)
Figure North America Bispecific Antibody Market PEST Analysis
Table Europe Bispecific Antibody Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Bispecific Antibody Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Bispecific Antibody Import and Export from 2015-2020
Table Europe Bispecific Antibody Value ($) by Type (2015-2020)
Table Europe Bispecific Antibody Production by Type (2015-2020)
Table Europe Bispecific Antibody Consumption by Application (2015-2020)
Table Europe Bispecific Antibody Consumption by Country (2015-2020)
Table Europe Bispecific Antibody Consumption Value ($) by Country (2015-2020)
Figure Europe Bispecific Antibody Market PEST Analysis
Table Asia-Pacific Bispecific Antibody Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Bispecific Antibody Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Bispecific Antibody Import and Export from 2015-2020
Table Asia-Pacific Bispecific Antibody Value ($) by Type (2015-2020)
Table Asia-Pacific Bispecific Antibody Production by Type (2015-2020)
Table Asia-Pacific Bispecific Antibody Consumption by Application (2015-2020)
Table Asia-Pacific Bispecific Antibody Consumption by Country (2015-2020)
Table Asia-Pacific Bispecific Antibody Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Bispecific Antibody Market PEST Analysis
Table Latin America Bispecific Antibody Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Bispecific Antibody Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Bispecific Antibody Import and Export from 2015-2020
Table Latin America Bispecific Antibody Value ($) by Type (2015-2020)
Table Latin America Bispecific Antibody Production by Type (2015-2020)
Table Latin America Bispecific Antibody Consumption by Application (2015-2020)
Table Latin America Bispecific Antibody Consumption by Country (2015-2020)
Table Latin America Bispecific Antibody Consumption Value ($) by Country (2015-2020)
Figure Latin America Bispecific Antibody Market PEST Analysis
Table Middle East & Africa Bispecific Antibody Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Bispecific Antibody Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Bispecific Antibody Import and Export from 2015-2020
Table Middle East & Africa Bispecific Antibody Value ($) by Type (2015-2020)
Table Middle East & Africa Bispecific Antibody Production by Type (2015-2020)
Table Middle East & Africa Bispecific Antibody Consumption by Application (2015-2020)
Table Middle East & Africa Bispecific Antibody Consumption by Country (2015-2020)
Table Middle East & Africa Bispecific Antibody Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Bispecific Antibody Market PEST Analysis
Table Global Bispecific Antibody Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Bispecific Antibody Production and Growth Rate Forecast by Region (2020-2027)
Table Global Bispecific Antibody Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Bispecific Antibody Production and Growth Rate Forecast by Type (2020-2027)
Table Global Bispecific Antibody Consumption and Growth Rate Forecast by Application (2020-2027)
